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In the majority of bacterial and viral infections the generation of cytotoxic T cells is of particular interest because
such pathogens are able to escape the host defence mechanisms by surviving intracellularly within the phagocytic
cells. To generate a CD81 T lymphocyte response against exogenous antigens, the prerequisite is their delivery
into the cytosol followed by processing and presentation along with class I major histocompatibility complex
(MHC-I) molecules. In the present study we describe the method of liposome-based delivery of antigens and
other macromolecules into the cytosol of target cells. To develop safe and effective methods for generating CD81
T lymphocytes, we exploited the fusogenic character of lipids derived from lower organisms, that is baker's yeast
(Saccharomyces cerevisiae). The degree of fusion with model membrane systems using yeast lipid liposomes
varied from 40±70%, as opposed to 1±8% observed with egg PtdCho liposomes, depending on the assay system
used. The fusion of yeast lipid liposomes with macrophages resulted in effective delivery of the entrapped solutes
into the cytoplasmic compartment. This was further supported by the inhibition of cellular protein synthesis in
J774 A1 cells by ricin A, encapsulated in the yeast lipid liposomes. Interestingly, the model antigen ovalbumin,
when entrapped in the yeast lipid liposomes, successfully elicited antigen reactive CD81 T cell responses. It may
be concluded that the liposomes made of lipids derived from S. cerevisiae can spontaneously fuse with
macrophages, delivering a significant portion of their contents into the cytoplasmic compartment of the cells.
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CD81 cytotoxic T cells play an important role in the protection
against a variety of intracellular infections. The prompt
development of cytotoxic T cell responses has been shown to
be crucial for protecting the host against diseases caused by
Trypanosoma cruzi [1,2], Toxoplasma gondii [3], Myco-
bacterium tuberculosis [4], Leishmania donovani [5] Listeria
monocytogenes [6,7] and viruses [8]. To mount an effective
immunity against these diseases, it is therefore, important to
develop vaccines that generate a strong CD81 T cell response.
Normally, the protein antigens delivered to antigen
presenting cells (APCs) are taken up by endocytosis. The
antigen is then processed within the endosomes to produce the
peptides that generally bind to class II major histocompatibility
complex (MHC-II) molecules. This results in the activation of
CD41 T cells [9]. CD41 T-helper (Th) cells provide aid to
cytotoxic T cells (CTL) and B cell in their various
immunological responses.
Cytotoxic T cells represent the other effector arm of the cell-
mediated immune responses. These cells are considered to be of
strategic importance in the killing of cells infected with
intracellular pathogens. The CD81 T cell phenotype can
considerably influence the outcome of infection by intracellular
pathogens. However, for eliciting the CD81 T cell responses,
the antigen is required to be processed and presented by the
MHC I antigen presentation pathway [10,11]. In order to
generate the CD81 T lymphocyte response, it is obligatory that
antigen should be in the cytosol of the antigen presenting cells.
Exogenous antigen can, however, enter the class I processing
pathway if it is delivered in a vehicle that is able to undergo
fusion with either the plasma membrane under normal
physiological conditions or the endosomal membrane at low
pH. Earlier investigators have attempted to use pH sensitive
liposomes [12,13] or virosomes [14,15] for protein delivery
into the cytosol. Such vehicles are likely to prove toxic to
the host, however, and involve cumbersome methods for their
preparation. These limitations restrict their use as vehicles for
delivering the newer generation of vaccines against intracellular
infections.
In lower organisms the plasma membrane is mainly
composed of amino-phospholipids along with cardiolipin and
phosphatidyl glycerol. The eukaryotic plasma membrane lipid
composition is different from that of lower organisms and
earlier work from our laboratory revealed the composition and
distribution of phospholipids in eukaryotic cells [16]. They
contain all classes of phospholipids, distributed in a set fashion
in the two leaflets of the bilayer. The amino-phospholipids are
mainly confined to the inner leaflet and play a major role in
exocytosis, which involves membrane±membrane fusion. This
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type of architectural difference in lipid distribution certainly
implies an evolutionary trend of biological significance. We
recently demonstrated that asymmetric distribution of phospho-
lipids is also maintained in yeast cells [17,18]. However, similar
to other lower organisms, yeast cells undergo rapid cell
duplication, in which the two opposite sites of the inner
leaflet come close to each other and fuse under physiological
conditions. Saccharomyces cerevisiae, a representative yeast,
has been generally regarded to be safe, and is easy to cultivate.
We therefore considered it of interest to utilize the fusogenic
properties of the vesicles formed from yeast lipids to deliver
antigen to APCs.
In the present study, we have analyzed the fusogenic
properties of yeast lipid liposomes. The liposomes displayed
a high tendency to undergo spontaneous membrane fusion
under physiological conditions with both model membrane
systems as well as intact cells. We have demonstrated that the
range of macromolecules encapsulated in the yeast lipid
vesicles could be readily introduced into the cytoplasmic
compartment of target cells. In addition, we have also shown
that ovalbumin entrapped in the vesicles could generate a strong
ovalbumin-specific CD81 T cell response.
M A T E R I A L S A N D M E T H O D S
Animals
Male Balb/c mice (8±10-week-old; 20 ^ 2 gm weight) were
obtained from the Institute's Animal House Facility (Institute of
Microbiol Technology, Chandigargh, India).
Chemicals and reagents
Egg PtdCho (PtdCho) was prepared using the standard method
[19]. Cholesterol was purchased from Centron Research
Laboratory, Bombay, India, and crystallized three times from
methanol prior to use. Calcein (Alfa Division of Ventron Corp.,
Denver, MA) was a kind gift from G. C. Varshney (Institute of
Microbiol Technology, Chandigargh, India). Peptone and yeast
extract were from Hi Media Laboratories, Bombay, while
dextrose was from S. D. Fine Chemicals, Boisar, India. DMEM,
Hanks' balanced salt solution (HBSS) and fetal bovine serum
were obtained from Life Technologies (Grand Island, New
York, USA). Fluorescein isothiocyanate (FITC)-labeled lectin
from Phaseolus vulgaris (FITC-PHA), FITC-dextran
(69 kDa), ovalbumin, lysozyme (chicken egg white), deglyco-
sylated ricin A, imidazole, percoll, Sephadex G-50, Sepharose
6B, and EDTA were from Sigma Chemical Company (St Louis,
MO, USA). l-Aminonapthaline-3,6,8-trisulphonic acid (ANTS)
and N,N 0-p-xylylenebis (pyridinium bromide) (DPX) were
bought from Molecular Probes, Inc. l-a-phosphatidyl-
ethanolamine-N-(4-nitrobenzo-2-oxa-1,3-diazole) (NBD-PE)
and N-(lissamine rhodamine B sulphonyl) phosphatidyl ethano-
lamine (Rh-PE) (Avanti polar lipids) were a kind gift from Dr
Anu Puri (NIH, Frederick, MD). Anti-IAd, anti-Mac 2 and anti-
L3T4 were gifts from Dr Gyan Mishra (IMT, Chandigarh, India).
125I-labeled Sodium iodide (carrier free), [35S]l-methionine
and [51Cr]sodium chromate were bought from Bhabha Atomic
Research Center, Trombay, India. Lysozyme was radio
iodinated using the published method [20]. The amount of
protein entrapped in the liposomes was determined using the
BCA protein assay (Pierce Chemical Company). J 774 A1, a
macrophage cell line, was procured from American Type
Culture Collection (Rockville, MD, USA) and was grown in
DMEM (pH 7.2) containing l-glutamine (4 mm), sodium
pyruvate (110 mg´L21), penicillin (100 U´mL21), streptomycin
sulfate (100 mg´mL21) and sodium bicarbonate (3.7 g´L21)
in 75 mL plastic bottles (Costar, MA, USA) at 37 8C under
7.5% CO2.
Yeast lipids
S. cerevisiae (NCYC 366) was cultured in YPD media (1%
yeast extract, 2% peptone and 2% dextrose pH 6.0). The cells
were harvested from mid-log phase (14±16 h) and pelleted at
2000 g for 10 min. The cell pellet was suspended in methanol
and sonicated for 60 min in a bath-type sonicator (0±4 8C) and
finally lipids were extracted following the published procedure
[21].
Yeast lipid composition
Total phospholipid (53.6 ^ 1.2%, w/w), total glycolipid
(7.8 ^ 1.3%, w/w) and total sterol (14.7 ^ 1.1%, w/w)
contents in the yeast lipid extract were determined following
the published procedures [22]. The total phospholipid compo-
sition (PtdCho, 48.1 ^ 0.7%; phosphatidyl-ethanolamine,
23.1 ^ 1.7%; phosphatidylinositol, 16.1 ^ 0.7%; phosphati-
dylserine, 6.0 ^ 0.6%; phosphatidylglycerol, 3.9 ^ 0.8%;
cardiolipin, 1.6 ^ 0.3%) in the mixture was analyzed as
described earlier [21].
Lipid vesicles
Large unilamellar vesicles (LUVs) were prepared essentially by
the freeze-thaw method [23]. The outer diameter of these
vesicles was about 140 1 50 nm. LUVs for resonance energy
transfer (RET) experiments were formed using yeast lipids (or
egg PtdCho), NBD-PE and Rh-PE in a molar ratio of
98.4 : 1 : 0.6. For the aqueous content mixing experiments,
LUVs were prepared by hydrating yeast lipids or egg PtdCho
(15 mmol lipid P) with 1.5 mL of 10 mm Tris-HCI (pH 7.5),
containing ANTS (25 mm) and NaCl (40 mm) or DPX
(90 mm). The entrapped ANTS (or DPX) from free ANTS
(or DPX) was separated by gel filtration using a Sephadex G-50
column.
Dried reconstituted vesicles (DRVs) were formed using the
known method [24]. Finally, free-flowing, lyophillized, dried
powder was rehydrated with distilled water and reconstituted in
NaCl/Pi. The preparation was centrifuged at 14 000 g and the
pellet was washed at least three times with NaCl/Pi to remove
traces of the unentrapped solute.
Erythrocyte membrane vesicles
Erythrocytes from fresh human blood were isolated by
removing the plasma and buffy coat. The cells were lysed
and then resealed after washing three times with the lysis buffer
[25]. The erythrocyte membrane vesicles thus prepared were
pelleted at 1200 g (15 min, 4 8C). After washing several times,
the preparation was resuspended in NaCl/Pi for further use.
RET assay
The lipid mixing between the NBD/rhodamine-labeled yeast
lipids (or egg PtdCho) LUVs (about 600 nmol, lipid P) and
unlabeled yeast lipid (or egg PtdCho) LUVs or erythrocyte
membrane vesicles (about 3.5 mg protein) was followed by
monitoring RET [26] between NBD (absorption, 470 nm;
emission, 520 nm) and rhodamine (absorption, 536 nm;
emission, 585 nm). The excitation wavelength was chosen to
be 20 nm below the absorption maxima of NBD to allow a
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better resolution between the scattered light peak and the NBD
emission peak, and also to minimize the direct excitation of
rhodamine. The efficiency (E) of RET was calculated as
follows:
E  1 2 F/Ft
where F is the NBD fluorescence in the presence of rhodamine,
and Ft is the NBD fluorescence at the maximal dequenching,
which was measured after disrupting the vesicles with Triton
X-100 (1% final concentration).
Aqueous content mixing assay
Quenching of the ANTS fluorescence by DPX was monitored
to follow the mixing of the aqueous contents of the vesicles
undergoing fusion [27]. The ANTS-containing LUVs were
mixed with an excess (10-fold) of the DPX-containing LUVs in
a total volume of 3 mL. The mixture was incubated at 37 8C
and the ANTS fluorescence was measured at varying periods of
time. The ANTS fluorescence observed at zero minutes was
taken as 100% fluorescence while the fluorescence values
observed after lysing a mixture of ANTS-containing and
DPX-containing LUVs with Triton X-100 (1% final concen-
tration) were taken as 0% fluorescence. The excitation and
emission wavelengths used were 380 nm and 540 nm,
respectively.
Macrophage±yeast lipid DRV interaction
The interaction of the macrophage with the yeast lipids DRVs
was monitored by observing the transfer of fluorescently
labeled water-soluble as well as membrane markers from the
vesicles to the macrophages.
Transfer of fluorescent membrane markers. Membranes of
DRVs were fluorescently labeled by incorporating NBD-PE
(5 mol percentage) in egg PtdCho/cholesterol or yeast lipids.
The J774 A1 cells (1  106 per well) were cultured overnight
in a 24-well plate. The cells were washed with DMEM, and
incubated with NBD-labeled DRVs (600 mmol lipid P per well)
for different time periods. The incubated cells were washed
once with DMEM and three times with NaCl/Pi. The washed
cells were fixed, and scrapped off the culture plates using
Versene solution (DMEM supplemented with 3 mm EDTA and
1% fetal bovine serum). The cells were washed three times with
NaCl/Pi and were analyzed for NBD fluorescence (excitation:
470 nm, emission: 520 nm), using log amplifiers on a Lysis II
software of FACS-analyzer (Becton Dickinson, Mountain View,
CA, USA). Ten-thousand cells (events) were acquired on Lysis
II software after `live' gating on the log forward scatter/NaCl/
Cit parameter, and the fluorescence was measured on gated
cells only. The analysis of mean fluorescence intensity was
done on histograms, where abscissa and ordinate denote log
NBD fluorescence and relative cell counts, respectively.
Transfer of water soluble fluorescent markers. Three water
soluble fluorescent markers (calcein, FITC-dextran and
FITC-PHA) were used in this study. The J774 A1
(1  106 cells) were cultured overnight on a sterile cover slip
in DMEM containing 10% fetal bovine serum. The cells were
washed with DMEM and incubated at 4 8C for 2 h. After
washing once with fetal bovine serum-free DMEM, the cells
were pulsed with calcein, FITC-dextran or FITC-PHA con-
taining DRVs (600 mmol lipid) for 60 min in fetal bovine
serum-free DMEM at 37 8C. After washing, the fixed
macrophages were observed under Leitz fluorescence micro-
scope at 100, using an I 3 filter.
Intracellular localization of lysozyme
DRVs loaded with 125I-labeled lysozyme (about 4  105
c.p.m.´mg21 protein) were used in these experiments.
J774 A1 cells (5  106 cells per well) were cultured in six-
well plates, incubated for 1 h at 37 8C with lipid vesicles. The
cells were washed with NaCl/Pi followed by fixation with
1% paraformaldehyde solution. The cells were detached
from the culture plates using chilled Versene solution. The
cells were broken following the published procedure by the
nitrogen cavitation method using Parr bomb and pelleted by
centrifuging at 750 g for 15 min [28]. The supernatant was
further centrifuged at 105 g for 1 h at 4 8C using a Beckman
L8±55 m ultracentrifuge. The pellet was suspended in 3.0 mL
of imidazole buffer (3 mm imidazole, 0.25 m sucrose; pH 7.4),
and then fractionated into plasma membrane/nucleus, cytosol,
endosome/lysosome, and other organelles (on the basis of
enzyme marker assay), as described earlier [28].
Inhibition of protein synthesis in the macrophages by ricin A
J774 A1 cells (1  106 cells per well) were cultured in a
24-well plate overnight at 37 8C. Next day, the cells were
incubated separately with free ricin A, or encapsulated in egg
PtdCho/chol DRVs and yeast lipid DRVs at 37 8C for 1 h. The
cells were washed, and then pulsed with l-[35S]methionine
(1 mCi per well) in a total volume of 200 mL per well for 6 h at
37 8C. The cells were washed two times with DMEM and were
treated with 7 m guanidine (50 mL per well). The final volume
was made up to 200 mL per well with NaCl/Pi. The suspension
was vortexed, and a small aliquot (20 mL) from the cell
lysate, was withdrawn in Eppendorff tubes. The lysate was
then treated with trichloroacetic acid (25%, 100 mL) and
bovine serum albumin (BSA; 1%, 50 mL), and centrifuged. The
precipitate was washed once with 10% tricholoroacetic acid and
counted for b-emission in a RackBeta Scintillation Counter,
after suspending in 10 mL of Scintillation fluid.
CD81 T lymphocyte response
Effector cells. Different groups of Balb/c mice were injected
separately with three different doses of free ovalbumin, yeast
lipid DRVs with no ovalbumin (sham liposomes), free
ovalbumin mixed with sham liposomes, ovalbumin encap-
sulated in egg PtdCho/chol or yeast lipid DRVs (100 mg per
animal per week) for 3 weeks. On day 21, animals were
sacrificed and spleens were removed aseptically. The splenic
tissue was macerated, and the supernatant separated by simple
decantation. The erythrocytes were removed by treatment with
Gey's solution (3 mL per spleen) for 10 min on ice [29]. The
cells were washed three times with HBSS, and then allowed to
adhere at 37 8C for 1 h to get rid of the macrophages. The
remaining cells were passed through a nylon wool column to
remove B lymphocytes. The residual macrophages and B cells
together with CD41 T lymphocytes were finally removed by
treating the above cell suspension with a cocktail of anti-Mac 2
Ab (2 mg per spleen), anti-L3T4 Ab (2 mg per spleen) and
anti-IAd Ab (3 mg per spleen) at 4 8C for 30±45 min, followed
by treatment with baby rabbit complement at 37 8C for 30 min.
The dead cells were removed by the Ficoll±Hypaque density
gradient method. The remaining cells, rich in CD81 T cells,
were washed with cold HBSS, counted, and used in the
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experiments. The enriched population stained with anti-CD8
Ab, was .98% pure, as evaluated by FACScan.
Target cells. Balb/c mice were injected with thioglycollate
broth. On day 4, peritoneal macrophges were harvested and
washed three times with HBSS. The cells (about 2  107 cells
per mL) were incubated separately with ovalbumin encap-
sulated in DRVs and free ovalbumin, at 37 8C for 1±2 h. The
cells were washed three times to remove the free antigen. This
was followed by incubation with 51Cr (100 mCi, 51Cr for
2  107 cells) for 45±60 min at 37 8C. The cells were finally
washed with RPMI solution and were used as target cells.
Cytotoxicity assay. The 51Cr-labeled macrophages (1  106 per
500 mL) were incubated with CD81 T cells (1  107 per
500 mL) at 37 8C for 6 h. The cells were pelleted at 3000 g
(15 min, 5 8C), and the amount of 51Cr released was
determined by measuring the radioactivity in the supernatant.
In another set of experiments, the fixed number of target cells
was incubated with effector cells at different target : effector
cell ratios and again target cell lysis was determined by
measuring 51Cr release. Total 51Cr release was calculated by
treating an aliquot of the cell suspension with Triton X-100
(10% final concentration). Auto release of 51Cr was determined
by incubating the 51Cr labeled macrophages for 6 h, and then
measuring the radioactivity released in the supernatant. The
amount of auto release was substracted from the total
release to determine the extent of macrophage lysis. In most
experiments, the auto (spontaneous) release was less than
25%. The percentage specific release was calculated as the
(mean sample c.p.m. 2 mean spontaneous c.p.m. / mean
maximum c.p.m. 2 mean spontaneous c.p.m.)  100% [13].
R E S U L T S
Fusion of yeast lipid LUVs with model membrane systems
LUV±LUV fusion. The LUV±LUV fusion was assessed by
monitoring the mixing of both the membrane lipids and the
Fig. 1. Efficiency over time of RET between NBD and rhodamine incorporated onto the surface of LUVs upon mixing labeled LUVs with increasing
amounts of unlabeled LUVs (A) and time-dependent quenching of ANTS fluorescence after mixing ANTS-containing LUVs with DPX-containing
LUVs in a ratio of 1 : 10 (B). (A) Filled symbols, egg PtdCho; open symbols, yeast lipids; diamonds, unlabeled : labeled LUV ratio  1; rectangles,
unlabeled : labeled LUV ratio  2; triangles, unlabeled : labeled LUV ratio  4; circles, unlabeled : labeled LUV ratio  10. Experiments were also
carried out by diluting the NBD/rhodamine labeled egg PtdCho LUVs (600 nmol lipid P) with the unlabeled yeast lipid LUVs (6000 nmol lipid P) or the
NBD/rhodamine labeled yeast lipids LUVs (600 nmol lipid P) with the unlabeled egg PtdCho LUVs (6000 nmol lipid P). The incubations were carried out for
60 min at 37 8C. The RET efficiency in the experiments decreased to 50.73 ^ 3.67% and 79.99 ^ 2.2%, respectively. Values are the mean of three
measurements. (B) Egg PtdCho LUVs, X; yeast lipid LUVs, W. Values are the mean of three measurements. (C) Interactions of the NBD-labeled yeast lipid
LUVs with the erythrocyte membrane vesicles. Yeast lipids (or egg PtdCho) LUVs (750 nmol lipid P per mL) containing 5 mol percentage NBD-PE in their
bilayers were interacted with varying concentrations of right-side-out erythrocyte membrane vesicles at 37 8C for one hour. The percentage of NBD
dequenching was calculated as given in Fig. 2B. Egg PtdCho LUVs, X; yeast lipids LUVs, W. Values are the mean of three measurements. (D) Efficiency
over time of RET between NBD and rhodamine incorporated onto the surface of LUVs upon mixing labeled LUVs (600 nmol lipid P) with the erythrocyte
membrane vesicle (3.5 mg protein). Egg PtdCho LUVs, X; yeast lipids LUVs, W. Values are the mean of three measurements.
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aqueous contents. The lipid mixing was followed by measuring
RET between NBD (photon donor) and rhodamine (photon
acceptor). These probes were grafted on the LUVs surface by
including NBD-PE and Rh-PE in egg PtdCho or yeast lipids.
The LUVs containing these two fluorophores (labeled vesicles)
were diluted with increasing amounts of the LUVs free of these
fluorophores (unlabeled vesicles). The efficiency of RET was
calculated by measuring the NBD fluorescence, as described in
Materials and methods. As the efficiency of RET between these
fluorophores has been shown to depend on their concentration
in the vesicle bilayer [26], it was expected that any fusion
between the labeled and unlabeled LUVs would lead to dilution
of the probes and consequently to a reduction in RET
efficiency. Unlike the egg PtdCho LUVs, the RET in the case
of the yeast lipid LUVs decreased with an increase in the
incubation time as well as in the concentration of the unlabeled
LUVs; the efficiency decreased to about 60% when the
unlabeled : labeled yeast lipid LUVs ratio was 10 (Fig. 1A).
However, this efficiency decreased to only 80% when the
labeled yeast lipid LUVs were diluted with a 10-fold excess of
the egg PtdCho LUVs. The `probe dilution' method is known to
be insensitive to vesicle aggregation [30] and the fluorescent
probes employed (NBD and rhodamine) have been shown not
to undergo any exchange between the phospholipid vesicles
[31]. We infer that the observed decrease in the RET efficiency
is certainly due to vesicle±vesicle fusion. To further examine
the validity of this conclusion, we monitored the mixing of the
aqueous contents during fusion by measuring quenching of the
ANTS fluorescence by the water soluble quencher DPX.
Incubation of the ANTS containing yeast lipid LUVs with
a 10-fold excess of DPX-containing LUVs resulted in about
70% quenching of the ANTS fluorescence in 15 min
(Fig. 1B). Unlike this finding, no such quenching of the
ANTS fluorescence was observed when ANTS-containing
egg PtdCho LUVs were incubated with 10-fold excess of the
DPX-containing egg PtdCho-LUVs in identical conditions.
These results clearly indicate that the yeast lipid LUVs have a
strong tendency to undergo fusion with each other as well as
with egg PtdCho LUVs. While the extent of membrane fusion
seems to vary from 40±70% depending on the assay used, only
about 20% fusion of yeast lipid vesicles was observed with egg
PtdCho LUVs.
LUV±erythrocyte membrane fusion. Fusion of the yeast lipid
LUVs with the erythrocyte membrane vesicles was studied by
including a self-quenching concentration (5 mol percentage) of
NBD-PE [32] in the yeast lipids or egg PtdCho LUVs bilayer.
The NBD fluorescence dequenching was measured by the
fluorescence light microscopy and fluorometry, subsequent to
the fusion of these LUVs with the erythrocyte membrane
vesicles. These results indicate that unlike the egg PtdCho
LUVs, yeast lipid LUVs readily fuse with erythrocyte
membrane vesicles, leading to about 60% dequenching of the
NBD fluorescence in a concentration-dependent (Fig. 1C) as
well as a time-dependent (Fig. 2B) manner. To further establish
our findings, we measured RET between NBD and rhodamine
after incubating the yeast lipid (or egg PtdCho) LUVs labeled
with these two fluorophores with a limited amount of the
erythrocyte membrane vesicles. Figure 1(D) shows that even
under these conditions, the yeast lipid LUVs, unlike the egg
PtdCho LUVs, undergo membrane fusion with the erythrocyte
membrane to an extent of about 20%. The transfer of
fluorescent probe to the erythrocyte ghost was further
confirmed by fluorescence micrographs shown in Fig. 2A.
Fusion of yeast lipid DRVs with cells
Transfer of water-soluble and membrane fluorescent markers.
Fusion of the yeast lipid DRVs with the macrophage cell line
J774 A1 was followed by monitoring the transfer of both the
Fig. 2. Interactions of NBD-labeled yeast lipids LUVs with the
erythrocyte membrane vesicles. Yeast lipids (or egg PtdCho) LUVs (750
nmol lipid P per mL) containing 5 mol percentage NBD-PE in their bilayers
were interacted with right-side-out erythrocyte membrane vesicles (1  108
vesicles per mL) at 37 8C for varying periods of time. The NBD
fluorescence was monitored up to 60 min incubation, using the excitation
and emission wavelengths of 470 nm and 520 nm, respectively. The
percentage of NBD dequenching was calculated as follows: % dequench-
ing  100  (F 2 Fo) / (Ft 2 Fo), where F, Fo and Ft are the fluores-
cence intensities at time `t', 0 min, and after adding Triton X-100 (1% final
concentration), respectively. After completing 60 min of incubation, the
erythrocyte membrane vesicles were pelleted by centrifugation at 1200 g,
and washed several times with NaCl/Pi. The fluorescence associated with
these vesicles was observed using a fluorescence light microscope. (A) A
and D, phase contrast and fluorescence light micrographs, respectively, of
the erythrocyte membrane vesicles interacted with egg PtdCho LUVs for
60 min; C and D, phase contrast and fluorescence light micrographs,
respectively, of the erythrocyte membrane vesicles interacted with yeast
lipids LUVs for 60 min. (B) Time-dependent NBD-fluorescence dequench-
ing upon interaction of NBD-labeled LUVs with erythrocyte membrane
vesicles. Egg PtdCho LUVs, V yeast lipids LUVs, P.
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water soluble fluorescent solutes and fluorescent membrane
markers from DRVs to the cells. For this purpose, the yeast
lipid (or egg PtdCho) DRVs loaded with calcein, FITC-dextran
or FITC-PHA were incubated with J774 A1 cells. After
removing DRVs that did not interact, the cells were observed
using a fluorescence light microscope. In each case, a
significant amount of these solutes was transferred by the
yeast lipid DRVs but not by the egg PtdCho/chol DRVs to the
cytoplasmic compartment of the cells by membrane fusion
(Fig. 3). To further corroborate our results, the yeast lipids
(or egg PtdCho/chol) DRVs containing 5 mol percentage of
NBD-PE in the bilayers were allowed to interact with J774 A1
cells. The transfer of the NBD fluorescence from DRVs to the
macrophage membrane was analyzed by the fluorescence light
microscopy (results not shown) and flow cytometry. A
substantial amount of the NBD fluorescence was transferred
to the plasma membranes of the cultured macrophages after
their incubation with the NBD-labeled yeast lipid DRVs. The
FACScan data revealed that the macrophage-associated NBD
fluorescence, after incubating the cells with the yeast lipid
DRVs, was at least 20 times higher than that observed with the
egg PtdCho/chol DRVs (Fig. 4). Further, our findings also
suggest that the incubation of the cells with the yeast lipid
vesicles in the presence of 100 mm chloroquine or at 0 8C
did not appreciably affect the NBD-PE transfer (data not
shown).
Intracellular distribution of 125I-labeled lysozyme. To analyze
the interactions between the yeast lipid vesicles and J774 A1
cells, we incubated the cells with yeast lipid DRVs containing
125I-labeled lysozyme. The intracellular distribution of lyso-
zyme was measured as described in the Materials and methods.
About 15.0% of the total cell associated 125I-labeled lysozyme
was localized in the cytosolic portion of the macrophages
that were incubated with the yeast lipid DRVs loaded with
125I-labeled lysozyme (Table 1). In contrast, only 1.8% of
the cell-associated radioactivity could be detected in the
cytoplasmic compartment of the cells that were treated with
the 125I-labeled lysozyme loaded egg PtdCho/chol DRVs.
These results clearly suggest that the yeast lipid DRVs possess
a strong fusogenic character that enables them to deliver the
entrapped solutes into the cytosolic compartment of the antigen
presenting cells.
Inhibition of the macrophage protein synthesis by ricin A. To
further examine whether the membrane±membrane fusion
constitutes one of the major modes of interaction between the
yeast lipid DRVs and the J774 A1 cells, we also studied the
effect of ricin A on macrophage protein synthesis. The cells
were incubated with DRVs loaded with the toxin. As without
the B-chain, ricin A is incapable of entering the cytosolic
compartment of the cells [33]. To exert any biochemical effect
on protein synthesis, ricin A needs a delivery system which can
undergo fusion with the plasma membrane of macrophages and
thereby deliver ricin A into the cytosyl. Our results indicate
that, unlike with free or egg PtdCho/chol DRVs, ricin A when
entrapped in yeast lipid DRVs did effectively inhibit macro-
phage protein synthesis in a dose dependent manner. (Fig. 5).
The delivery of the antigen entrapped in the fusogenic yeast
lipid DRVs elicits an effective immune response
For an exogenous antigen to elicit the CD81 T lymphocyte
response, the antigen must be delivered into the cytosol of the
antigen presenting cells [10,11]. The strong fusogenic character
Fig. 3. Interactions of J774 A.1 cells with DRVs loaded with fluorescent
solutes. (A) A and B, phase contrast and fluorescence light micrographs,
respectively, of the macrophages interacted for 60 min at 37 8C with egg
PtdCho/chol DRVs loaded with calcein. C and D, phase contrast and
fluorescence light micrographs, respectively, of the macrophages interacted
for 60 min at 37 8C with yeast lipids DRVs loaded calcein. Almost identical
light micrographs were observed when the macrophages were interacted
with calcein loaded DRVs in the presence of 100 mm chloroquine or at
4 8C. (B) A and B phase contrast and fluorescence light micrographs,
respectively, of the macrophages interacted for 60 min at 37 8C with egg
PtdCho/chol DRVs loaded with FITC-dextran. C and D, phase contrast and
fluorescence light micrographs, respectively, of the macrophages interacted
for 60 min at 37 8C with yeast lipid DRVs loaded with FITC-dextran. (C) A
and B, phase contrast and fluorescence light micrographs, respectively, of
the macrophages interacted for 60 min at 37 8C with egg PtdCho/chol
DRVs loaded with FITC-PHA. C and D, phase contrast and fluorescence
light micrographs, respectively, of the macrophages interacted for 60 min at
37 8C with yeast lipids DRVs loaded with FITC-PHA.
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of the great lipid DRVs is likely to facilitate cytosolic delivery
of the entrapped protein, and in principle, should generate a
strong CD81 T cell response. To examine the validity of this
prediction, we evaluated the ability of ovalbumin entrapped in
the yeast lipid DRVs to generate a CD81 T cell response. The
antigen-specific CD81 cytotoxic T cell response was measured
by 51Cr release assay. Interestingly, immunization with the
ovalbumin entrapped in the yeast lipid DRVs, but not other
forms of antigen (free ovalbumin or sham liposomes, or free
ovalbumin mixed with sham liposomes or ovalbumin entrapped
in egg PtdCho/chol DRVs) led to the generation of cytotoxic T
cells, as documented by the lysis of the target cells. A
considerably higher degree (30±40%) of macrophage lysis
occurred when the ovalbumin was encapsulated in the yeast
lipid DRVs than when in free form or in egg PtdCho/chol DRVs
(Table 2). The percent specific lysis of the target cells depends
on the target : effector ratio as depicted in Fig. 6. Furthermore,
these results also confirm the antigen specificity of CTLs
generated. Unrelated antigen (lysozyme) when incubated with
antigen presenting cells were not recognized by CTLs obtained
from ovalbumin primed animals (Fig. 6).
Fig. 4. FACS analysis of J774 A.1 cells after their interaction with
DRVs labeled with NBD-PE. A1, A2, A3 and A4 show cells interacted with
NBD-labeled egg PtdCho/chol DRVs for 0 min, 15 min, 30 min and
120 min, respectively. B1, B2, B3 and B4 show cells interacted with
NBD-labeled yeast lipid DRVs for 0 min, 15 min, 30 min and 120 min,
respectively.
Table 1. Subcellular distribution of 125I-lysozyme introduced in J774 A.I cells using yeast lipid DRVs as carriers.
Percent distribution of radioactivitya
Lipid vesicles Nucleus/plasma membrane Cytosol Endosome/lysosome Other organelles
Egg PtdCho/chol 12.5 ^ 1.40 1.80 ^ 0.50 71.23 ^ 3.20 13.60 ^ 1.70
Yeast lipids 61.11  3.40 15.41 ^ 1.20 20.41 ^ 2.90 2.63 ^ 0.50
a Values shown are means of three experiments ^ SD.
Fig. 5. Inhibition of the cellular protein synthesis by ricin A after J774
A.1 cells were interacted with ricin A-loaded yeast lipid DRVs. Free ricin
A, W; ricin A loaded in egg PtdCho/chol DRVs, K ricin A loaded in yeast
lipids DRVs, A. Values are the mean of three experiments.
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D I S C U S S I O N
A number of pathogens adapt intracellular parasitism as a
survival strategy that protects them against the action of host
humoral defense mechanisms. Protective immunity against
these intracellular pathogens (for example, tuberculosis,
leprosy, leishmaniasis, malaria, etc.), which thrive inside the
hostile environment of the cells of an immunocompetent host,
is considered to be essentially through cell-mediated immunity.
Important roles for CD41 and CD81 T lymphocytes have been
suggested by several studies of murine and human infections
[34±37]. The generation of CTLs occurs when the antigen is
delivered into the cytosol of the antigen presenting cells. In
contrast, T-helper cells recognize antigens that are delivered
exogenously and are processed in the class II antigen-
processing pathway. Exogenous antigens do not ordinarily
enter the class I processing pathway and thus do not activate
CD81 CTLs. However, they can enter the class I processing
pathway if they are delivered in a vehicle that has the property
of undergoing fusion either with the plasma membrane, under
normal physiological conditions or with the endosomal
membrane at low pH.
We have shown earlier that antigen incorporated into
conventional liposomes results in the enhancement of inter-
leukin-4 (IL-4) and IgG-1 secretion [38]. In the present work,
we have attempted to deliver exogenous antigen into the cytosol
of target cells using yeast lipid liposomes. The following major
findings have emerged from this study; yeast lipid vesicles
undergo efficient fusion with the cell membrane; the macro-
molecules entrapped in the liposomes can be delivered into the
cytosol of the target cells; the antigen entrapped in the yeast
lipid vehicles effectively delivers the content into the class I
antigen processing pathway; and effector CD81 cytotoxic T
cells are stimulated.
The present study shows that vesicles formed of a yeast lipid
extract have an inherent tendency to undergo spontaneous
membrane fusion. These vesicles fuse not only with each other
but also with egg PtdCho/chol vesicles, albeit to a lesser extent.
The extent of fusion with egg PtdCho liposomes was about
20%, as judged by measuring the RET between NBD-PE and
Rh-PE embedded in the yeast lipid vesicle bilayer. The RET
assay is known to be insensitive to vesicle aggregation [30] and
ensurees that the probes do not undergo exchange between the
membranes [31]. In the present study, the observed decrease in
RET efficiency upon incubation of yeast lipid vesicles
containing NBD-PE/Rh-PE with unlabeled yeast lipid (or egg
PtdCho/chol) vesicles or the erythrocyte membrane vesicles, is
directly used to calculate the extent of membrane fusion.
Similarly, the ANTS/DPX mixing used for assaying the mixing
of the aqueous content of the interacting vesicles appears to be
quite reliable, as quenching of the ANTS fluorescence by DPX
has been shown to be highly dependent on DPX concentration,
and it does not occur upon leakage of DPX into the medium
[30]. Further, the NBD-fluorescence dequenching assay used to
monitor the interactions of NBD-labeled yeast lipid vesicles
with the erythrocyte membrane vesicles (or macrophages)
would only monitor the membrane fusion, as NBD-PE has been
shown to be a nonexchangeable fluorescent lipid probe by
earlier investigators [31].
The fusion of the yeast lipid vesicles is not only restricted to
the model membrane systems but it could also occur with live
cells, such as macrophages. This is based on our observations
that transfer of both the water soluble fluorescent solutes and
the fluorescent membrane markers from the yeast lipid vesicles
to J774 A1 cells was considerably higher (at least 20-fold) than
Table 2. Ovalbumin-specific CD81 T lymphocyte response generated
by ovalbumin loaded yeast lipid DRVs in Balb/c mice. The ovalbumin-
specific CD81 T lymphocyte response was ascertained by measuring the
lysis of the antigen sensitized macrophages by the antigen-specific CD81 T
cells isolated from ovalbumin immunized mice, which in turn was
determined by measuring the 51Cr release. Results shown are of four
independent experiments. Each value is a mean of three determinations
^SD.
Antigen Percent 51Cr release
Saline 0.14  0.07
0.35 ^ 0.05
0.27 ^ 0.16
Free ovalbumin 0.02  0.04
0.00 ^ 0.00
0.50 ^ 0.28
0.25 ^ 0.03
Plain yeast lipid (sham) DRVs 0.08 ^ 0.04
0.76 ^ 0.15
Ovalbumin mixed with sham DRVs 0.45 ^ 0.20
0.84 ^ 0.16
Ovalbumin encapsulated in egg PtdCho/chol DRVs 0.78 ^ 0.29
0.80 ^ 0.16
0.00 ^ 0.00
0.00 ^ 0.00
Ovalbumin encapsulated in yeast lipid DRVs 37.45 ^ 1.40
38.85 ^ 3.45
30.00 ^ 3.45
33.10 ^ 1.80
Fig. 6. Effect of the CD81 T lymphocyte/macrophage ratio on lysis of
the ovalbumin-sensitized macrophages by CD81 T lymphocytes derived
from mice immunized with different forms of ovalbumin. Free
ovalbumin, K ovalbumin loaded in egg PtdCho/chol DRVs, W; ovalbumin
loaded in yeast lipids DRVs, A. In the case of control wells, target cells
incubated with effector cells (ovalbumin reactive CD81 T cells) in the
absence of antigen or with sham liposomes (no antigen) and unrelated
antigen (lysozyme entrapped in yeast lipids liposomes) did not show more
than 2% of 51Cr release.
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with egg PtdCho/chol vesicles. This transfer remained virtually
unaffected by lowering the incubation temperature from 37 8C
to 4 8C or by incorporation of 100 mm of chloroquine in the
incubation mixture. Furthermore, nearly 15% of cell-associated
125I-lysozyme could be localized in the cytosolic fraction after
J774 A1 cells were interacted with 125I-lysozyme-loaded yeast
lipid DRVs as opposed to about 2% using egg PtdCho/chol
DRVs. Unusually high incorporation of radioactivity (61%) was
seen in the plasma membrane/nuclear fraction of the interacted
cells (Table 1). This may be considered as the result of the
multilamellar nature of the yeast lipid DRVs, which have a
tendency to settle upon centrifugation even at lower g-values.
This is also evident from the fact that repetition of the same
study but substituting DRVs with LUVs resulted in a
remarkable increase in cytosolic delivery (up to 30%), and
only 13% of the total cell-associated radioactivity was localized
in plasma membrane/nuclear fraction (data not shown).
The results of the present investigation suggest that the yeast
lipid DRVs could undergo spontaneous membrane fusion with
J774 A1 cells, resulting in the delivery of the entrapped
material into their cytoplasmic compartment. This is further
established by our present finding that ricin A encapsulated in
yeast lipid DRVs, but not in free form or in egg PtdCho/chol
DRVs, strongly inhibited cellular protein synthesis upon its
interactions with J774 A1 cells. Our observation is further
substantiated by the fact that ovalbumin loaded in the yeast
lipid DRVs, but not in free form or in egg PtdCho/chol DRVs,
generated a strong ovalbumin-specific CD81 T lymphocyte
response [10,11].
It appears that antigen is only endocytosed when egg
PtdCho/chol vesicles interact with the APC. In contrast, the
yeast lipid vesicles appear to interact with the cells by both
endocytosis and membrane fusion, thus helping in the
activation of both T-helper cells as well as CTLs. It has
long been appreciated that both CD41 (helper) and CD81
(cytotoxic) T cells are required for immunity to virulent M.
tuberculosis. The requirement of CD41 recognition of infected
macrophages is very much illustrated by the synergy between
HIV and mycobacteria: HIV infection desolates the body's
CD41 T-helper cell population and allows the Mycobacteria to
grow unhindered. Besides, MHC-II or CD4 deficient mice are
susceptible to infection even with the avirulent Bacillus
Calmette-Guerin (BCG) strain of Mycobacterium bovis [39].
With this in mind, we extended our study to determine the role
of yeast lipid vesicles in the elicitation of CD41 T-helper cells.
The secretion of IL-2, IL-4 and interferon-g (IFN-g) was
evaluated in the supernatant of cells obtained from immunized
animals. We observed that antigen encapsulated in yeast lipid
DRVs generated strong CD41 T lymphocyte responses as well
(data not shown). Even the CD41 T cell response generated by
using the yeast lipid vesicles was better than that observed with
the egg PtdCho/chol DRVs. As both CD41 and CD81 T
lymphocyte responses seem to be required for effective control
of the mycobacterial infections, especially tuberculosis [40], it
may be inferred that encapsulation of protective mycobacterial
antigens [41,42] in yeast lipid vesicles may further improve
their effectiveness against these infections.
Lipid vesicles have been widely employed as vehicles to
deliver drugs and other biologically active substances to cells
both in vitro and in vivo [43±46]. Also, their use as vaccine and
nucleic acid carriers has been well documented [44,46±48]. In
addition, antisense nucleotide sequences entraped in lipid
vesicles have been successfully delivered to their target cells
[46]. As yeast lipid vesicles are easy to prepare and should
presumably be nontoxic to humans, their use as vehicles for
introducing biologically active substances, especially nucleic
acids and proteins, into the cytoplasmic compartment of cells
could prove advantageous over the use of other lipid vesicles.
It is not yet clear what factor gives rise to the strong
fusogenic character of the yeast lipid extract. However, earlier
studies with polyethylene glycol-resistant cell mutants have
shown that some of these mutants can readily undergo
spontaneous membrane fusion, and that the increased fusogenic
tendency of these cells is correlated with an increased
saturation of the fatty acyl chains as well as an increased
neutral ether-linked lipid content [49]. Furthermore, a glycero-
diPtdCho derivative linked to a polyol and an amino acid has
been shown to be the main factor responsible for fusion of
Mycoplasma to T lymphocytes [50,51]. But no such fusogenic
lipid factors have so far been identified in S. cerevisiae.
However, the lipid content of this yeast does include significant
quantities of anionic phospholipids, lysolipids, monoglycerides
and phosphatidylethanolamine [52], all of which are known to
be fusion inducers. Alternatively, membrane fusion can be
induced by fusogenic proteins present in cellular membranes
[53]. Our preliminary studies have, however, indicated that the
fusogenic character of yeast lipids is not influenced by passing
the lipid mixture through a silica gel column, using chloroform/
methanol (1 : 1, v/v) as the eluant, or by the prolonged
digestion of the lipid extract with pronase (data not shown).
Although this argues against the possible role of some
fusogenic proteins, which could be present as contaminants in
the yeast lipid extract, imparting a fusogenic character on the
lipid mixture, further studies are clearly required to reach a
definite conclusion.
In summary, this study demonstrates that lipids derived from
S. cerevisiae possess a strong fusogenic character. The vesicles
formed from these lipids readily fuse with target cells,
delivering a variety of water-soluble solutes, including macro-
molecules, to the cytoplasmic compartment. The quantities of
the delivered solutes are sufficient enough to exhibit an
intracellular biochemical effect as evidenced by inhibition of
the cellular protein synthesis by ricin A loaded in the yeast lipid
vesicles. Also, ovalbumin encapsulated in these vesicles
generated a strong ovalbumin-specific CD81 T lymphocyte
response, as well as generating the CD41 T cell response.
Finally we can conclude that the yeast lipid liposomes should
certainly provide a safe and promising adjuvant for inducing
cell-mediated immunity when attenuated live vaccines are
unavailable or impractical.
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